Effects of angiotensin converting enzyme inhibition on crossbridge properties of diaphragm in cardiomyopathic hamsters of the dilated bio 53-58 strain

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 2, 1997, Pages 630-636

  Lecarpentier, Y ^a   Coirault, C ^b   Lerebours, C ^b   Desche, P ^b   Scalbert, E ^b   Lambert, F ^b   Chemla, D ^b  

^a BICÊTRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ACTIN MYOSIN INTERACTION; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIAPHRAGM; HAMSTER; MUSCLE CONTRACTILITY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TONE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL;

EID: 0031059874     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.2.9032205     Document Type: Article

References (40)

1. De Troyer, A., M. Estenne, and J. C. Yernault. 1980. Disturbance of respiratory muscle function in patients with mitral valve disease. Am. J. Med. 69:867-873.
2. Hammond, M. D., K. A. Bauer, J. T. Sharp, and R. D. Rocha. 1990. Respiratory muscle strength in congestive heart failure. Chest 98:1091-1094.
3. McParland, C., B. Krishnan, Y. Wang, and C. G. Gallagher. 1992. Respiratory muscle weakness and dyspnea in chronic heart failure. Am. Rev. Respir. Dis. 146:467-472.
4. Mancini, D. M., D. Henson, J. LaManca, and S. Levine. 1992. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 86:909-918.
5. Mancini, D. M., D. Henson, J. La Manca, and S. Levine. 1994. Evidence of reduced respiratory muscle endurance in patients with heart failure. J. Am. Coll. Cardiol. 24:972-981.
6. Nishimura, Y., H. Maeda, K. Tanaka, H. Nakamura, Y. Hashimoto, and M. Yokoyama. 1994. Respiratory muscle strength and hemodynamics in chronic heart failure. Chest 105:355-359.
7. Ambrosino, N., C. Opasich, P. Crotti, F. Cobelli, L. Tavazzi, and C. Rampulla. 1994. Breathing pattern, ventilatory drive and respiratory muscle strength in patients with chronic heart failure. Eur. Respir. J. 7:17-22.
8. Evans, S. A., L. Watson, M. Hawkins, A. J. Cowley, I. D. A. Johnston, and W. J. M. Kinnear. 1995. Respiratory muscle strength in chronic heart failure. Thorax 50:625-628.
9. McParland, C., E. F. Resch, B. Krishnan, Y. Wang, B. Cujec, and C. G. Gallagher. 1995. Inspiratory muscle weakness in chronic heart failure: role of nutrition and electrolyte status and systemic myopathy. Am. J. Respir. Crit. Care Med. 151:1101-1107.
10. Chua, T. P., S. D. Anker, D. Harrington, and A. J. S. Coats. 1995. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. Br. Heart J. 74:381-385.
11. Lecarpentier, Y., P. Herve, A. Villeneuve, P. Lacroix, and P. Duroux. 1989. Alterations of in vitro diaphragm function during chronic heart failure in rabbit (abstract). Am. Rev. Respir. Dis. 139:A162.
12. Musch, T. I. 1993. Elevated diaphragmatic blood flow during submaximal exercise in rats with chronic heart failure. Am. J. Physiol. 265: H1721-H1726.
13. Supinski, G., A. DiMarco, and M. Dibner-Dunlap. 1994. Alterations in diaphragm strength and fatiguability in congestive heart failure. J. Appl. Physiol. 76:2707-2713.
14. Howell, S., J. M. I. Maarek, M. Fournier, K. Sullivan, W. Z. Zhan and G. Sieck. 1995. Congestive heart failure: differential adaptation of the diaphragm and latissimus dorsi. J. Appl. Physiol. 79:389-397.
15. Huxley, H. E. 1969. The mechanism of muscular contraction. Science 194:1356-1366.
16. Spudich, J. A. 1994. How molecular motors work. Nature 372:515-518.
17. Jasmin, G., and L. Proscheck. 1989. Comparative effetcs of calcium antagonists and of inotropic agents on the development of hereditary cardiomyopathy in the hamster. In F. Bender and W. Meesmann, editors. Treatment with Gallopamil. Steinkopff Verlag, Darmstadt. 13-23.
18. Burbach, J. A., E. H. Schlenker, and J. L. Johnson. 1987. Morphometry, histochemistry, and contractility of dystrophic hamster diaphragm. Am. J. Physiol. 253:R275-R284.
19. Chemla, D., E. Scalbert, P. Desché, J. C. Pourny, F. Lambert, and Y. Lecarpentier. 1992. Effects of perindopril on myocardial inotropy, lusitropy and economy, and on diaphragmatic contractility in the cardiomyopathic Syrian hamster. J. Pharmacol. Exp. Ther. 262:516-525.
20. Lecarpentier, Y., N. Pery, C. Coirault, E. Scalbert, P. Desché, I. Suard, F. Lambert, and D. Chemla. 1993. Intrinsic alterations of diaphragm muscle in experimental cardiomyopathy. Am. Heart J. 126:770-776.
21. Huxley, A. F. 1957. Muscle structure and theories of contraction. Progr. Biophys. Chem. 7:255-318.
22. Chemla, D., E. Scalbert, P. Desché, G. Lerebours, I. Suard, and Y. Lecarpentier. 1994. Effects of early and late therapy with perindopril on survival and myocardial inotropic state in experimental dilated cardiomyopathy. J. Cardiovasc. Pharamacol. 24:151-157.
23. Lecarpentier, Y., L. B. Bugaisky, D. Chemla, J. J. Mercadier, K. Schwartz, R. G. Whalen, and J. L. Martin. 1987. Coordinated changes in contractility, energetics and isomyosins after aortic stenosis. Am. J. Physiol. 252:H275-H282.
24. Hill, A. V. 1938. The heat of shortening and the dynamic constants of muscle. Proc. R. Soc. Lond. (Biol. Sci.) 126:136-195.
25. Alpert, N. R., and L. A. Mulieri. 1982. Myocardial adaptation to stress from the viewpoint of evolution and development. In B. M. Twaurog, R. J. C. Levine, and M. M. Dewey, editors. Basic Biology of Muscles: A Comparative Approach. Raven Press, New York. 173-188.
26. Eisenberg, E., T. L. Hill, and Y. D. Chen. 1980. Cross-bridge model of muscle contraction: quantitative analysis. Biophys. J. 29:195-227.
27. Rayment, I., W. R. Rypniewski, K. Schmidt-Base, R. Smith, D. R. Tomchick, M. M. Benning, D. A. Winkelmann, G. Wesenberg, and H. M. Holden. 1993. Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261:50-58.
28. Finer, J. T., R. M. Simmons, and J. A. Spudich. 1994. Single myosin molecule mechanics: piconewton forces and nanometre steps. Nature 368:113-119.
29. Huxley, A. F., and R. M. Simmons. 1971. Proposed mechanism of force generation in striated muscle. Nature 233:533-538.
30. Al-Zaid, N. S., M. S. Al-Adnani, and K. A. Gumaa. 1990. Collagen of the dystrophic hamster diaphragm. Thorax 45:878-879.
31. Nishizaka, T., H. Miyata, H. Yoshikawa, S. I. Ishiwata, and K. Kinosita. 1995. Unbinding force of a single motor molecule of muscle measured using optical tweezers. Nature 377:251-254.
32. Aubier, M., T. Trippenbach, and C. Roussos. 1981. Respiratory muscle fatigue during cardiogenic shock. J. Appl. Physiol. 51:499-508.
33. Lipkin, D. P., D. A. Jones, J. M. Round, and P. A. Poole-Wilson. 1988. Abnormalities of skeletal muscle in patients with chronic heart failure. Int. J. Cardiol. 18:187-195.
34. Massie, B. M., M. Conway, B. Rajagopalan, R. Yonge, S. Frostick, J. Ledingham, P. Sleight, and G. Radda. 1988. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure: evidence for abnormalities unrelated to blood flow. Circulation 78:320-326.
35. Sullivan, M. J., H. J. Green, and F. R. Cobb. 1990. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 81:518-527.
36. Drexler, H., U. Riede, T. Münzel, H. König, E. Funke, and H. Just. 1992. Alterations of skeletal muscle in chronic heart failure. Circulation 85:1751-1759.
37. The Consensus Trial Study Group. 1987. Effects of enalapril on mortality in severe congestive heart failure. N. Engl. J. Med. 316:1429-1435.
38. Haleen, S. J., R. E. Weishaar, R. W. Overhiser, R. F. Bousley, J. A. Keiser, S. R. Rapundalo, and D. G. Taylor. 1991. Effects of quinapril, a new angiotensin converting enzyme inhibitor, on left ventricular failure and survival in the cardiomyopathic hamster: hemodynamic, morphological, and biochemical correlates. Circ. Res. 68:1302-1312.
39. Lambert, F., Y. Lecarpentier, A. M. Lompré, E. Scalbert, P. Desché, and D. Chemla. 1995. Relations between myocardial contractility, myosin phenotype and plasma angiotensin-converting enzyme activity in the cardiomyopathic hamster. J. Cardiovasc. Pharmacol. 25: 410-415.
40. 2+ pump genes in heart and diaphragm of the cardiomyopathic Syrian hamster: the effect of angiotensin-converting enzyme inhibitor. Am. J. Physiol. 268:H1947-H1953.